About
Animedix
An AI-powered pharmaceutical intelligence platform for research, education, and analytics.
What we do
Animedix organises, analyses, and presents information from medical, scientific, regulatory, and industry sources. Our goal is to help clinicians, researchers, students, and other pharma-adjacent professionals explore complex information faster — from disease mechanism and drug pipelines to regulatory calendars and market activity.
The platform is designed as a tool for exploration and understanding, not as a source of professional advice. It does not provide medical advice, diagnosis, or treatment, and it does not provide financial or investment advice. Model outputs — including confidence scores, probability estimates, and signals — are analytical, not prescriptive. For the full framework, see our Platform Disclosures.
What's inside
Disease Education
ICD-10-organised disease library with mechanism-of-action videos, treatment landscapes, biomarker context, and links out to the published literature.
Drug Intelligence
Structured drug data — mechanism, clinical trials, associated diseases, regulatory context — aggregated from public sources and cross-referenced.
News & Expert Articles
Curated pharmaceutical news with weekly video reels, plus long-form expert articles authored by clinicians and researchers on the platform.
Research Analytics
Disease heat map comparing research activity and clinical pipeline density across therapeutic areas, powered by PubMed and ClinicalTrials.gov.
Investor Intelligence
Model-based signals for pharmaceutical companies and PDUFA events. Every output is presented as an estimate, not a recommendation.
Our sources
Animedix aggregates public and open-access data including PubMed, ClinicalTrials.gov, OpenFDA, Reactome, KEGG, WikiPathways, SEC EDGAR filings, and vetted news feeds. We do not control third-party sources and cannot guarantee their accuracy or completeness. Inclusion of any source does not constitute an endorsement.
How to use Animedix
Animedix is one informational resource among many. It is not a substitute for professional judgment, independent research, or expert advice. You should not treat platform outputs as instructions or recommendations. Decisions relating to patient care, investments, business strategy, or regulatory compliance should be made using independent judgment and, where appropriate, with qualified professional advice.
Company
Animedix is operated by Animedix by SIVRA Inc. For questions, partnerships, or press enquiries, please see our Contact page.